| Name | No. | Patient Profile | Purpose |
|---|---|---|---|
| MK3475-811 (KEYNOTE 811) | 18-12 | Cancer of the oesophagus or gastro-oesophageal junction which has spread (metastasised). |
To compare survival between the two groups – those treated with Trastuzumab, chemotherapy and Pembrolizumab and those treated with Trastuzumab, chemotherapy and placebo. |
| Name | No. | Patient Profile | Purpose |
|---|---|---|---|
| COLLOSUS | 17-26 | Patients with cancer of the colon or rectum which has spread (metastasised). |
To find and test new stratification tools (ways of dividing patients into different groups) in patients who have microsatellite stable RAS mutant metastatic colorectal cancer. |
| Name | No. | Patient Profile | Purpose |
|---|---|---|---|
| ARMO Artist | 16-77 | Patients with cancer of the pancreas which has spread (metastasised) |
This trial aims to compare the effectiveness of a drug called AM0010 in combination with FOLFOX with FOLFOX alone. |
| Name | No. | Patient Profile | Purpose |
|---|---|---|---|
| BMS CA209-577 | 16-73 | Cancer of the oesophagus, or the junction between the oesophagus and the stomach. |
The purpose of this trials is to determine the effectiveness of the drug nivolumab in patients with residual disease after CRT and surgery. |
| Name | No. | Patient Profile | Purpose |
|---|---|---|---|
| STRATEGIC-1 | 14-20 | Cancer of the colon or rectum. |
The purpose of this trial is to compare two standard chemotherapy treatment strategies. |
| Name | No. | Patient Profile | Purpose |
|---|---|---|---|
| BMS CA209-142 | 14-19 | Cancer of the colon. |
The purpose of this trial is to examine the effectiveness of the drug Nivolumab in combination with other drugs. |
| Name | No. | Patient Profile | Purpose |
|---|---|---|---|
| TRI-LARC | 12-38 | Cancer of the rectum. |
The purpose of this trial is to compare two radiotherapy techniques for treating locally advanced rectal cancer. |
| Name | No. | Patient Profile | Purpose |
|---|---|---|---|
| PDAC Plasma Biomarker | 12-31 | Pancreatic cancer |
The purpose of this trial is to investigate how proteins and genes respond to pancreatic cancer treatment. |
| Name | No. | Patient Profile | Purpose |
|---|---|---|---|
| CRAC Plasma Biomarker | 12-27 | Colorectal cancer (colon or rectal) |
The purpose of this trial is to investigate what proteins and genes are related to the recurrence of colorectal cancer. |
| Name | No. | Patient Profile | Purpose |
|---|---|---|---|
| Neo-AEGIS | 10-14 | Cancer of the oesophagus or the junction between the oesophagus and the stomach. |
The aim of this trial is to compare and evaluate two well-established standard of care treatments for cancer of the oesophagus in order to establish if one treatment is better than the other. |
